申请人:Iino Tomoharu
公开号:US20090018056A1
公开(公告)日:2009-01-15
Compounds having glucokinase activating effects and being useful as treatments for diabetes, which are represented by the following formula (I):
[wherein X
1
represents oxygen, etc., X
2
represents oxygen, etc., R
1
represents a group on Ring A such as alkylsulfonyl, etc., R
2
represents C3-7 cyclic alkyl optionally substituted with a halogen, etc., R
3
represents a substituent on Ring B such as lower alkyl, etc., formula (II):
[Chemical Formula 1]
represents 6- to 10-membered aryl, etc., and formula (III):
[Formula 1]
represents monocyclic or bicyclic heteroaryl optionally having on Ring B a substituent represented by R
3
above, wherein the carbon atom of Ring B which is bonded to the nitrogen atom of the amide group of formula (I) forms a C═N bond with the nitrogen atom of the ring],
as well as their pharmaceutically acceptable salts.
具有激活葡萄糖激酶效果且可用作糖尿病治疗的化合物,其化学式如下(I):[其中X1代表氧等,X2代表氧等,R1代表环A上的基团,例如烷基磺酰等,R2代表C3-7环状烷基,可选择地被卤素等取代,R3代表环B上的取代基,例如低烷基等,化学式(II):[化学式1]代表6到10成员芳基等,化学式(III):[化学式1]代表单环或双环杂芳基,可选择地在环B上具有由上述R3代表的取代基,其中环B的碳原子与化学式(I)的酰胺基团的氮原子形成C═N键与环的氮原子结合],以及其药学上可接受的盐。